RU5-16954-41055
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 717 / AR
- Registered
- 2022-04-01
- Relationship
- Child or adolescent in my care
- Guardian
- DPA-13780-92194
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-05-07
Dose 2 — Pfizer-BioNTech
-
2022-03-31
Dose 3 — Pfizer-BioNTech
-
2022-04-01
Registered in v-safe
-
2022-04-01
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-04-02
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-03
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2022-04-04
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Fever · Muscle or body aches, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2022-04-05
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2022-04-06
- 2022-04-07
- 2022-04-14
- 2022-04-23
- 2022-04-28
-
2022-05-05
Survey response — day 35, dose 3, dependentMedDRA: Chills, Dyspnoea, Headache, Hot flush, Lethargy, Nausea, Vomiting — Feeling: Poor · Be unable to work or attend schoolFree text: Nausea, headache, chills, vomiting, heat flash, lethargy, short of breathMedDRA releases: 2024-11 · check-in free text available
- 2022-05-12
- 2022-06-30
- 2022-09-29
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | No |
| 2 | 2021-05-07 | Pfizer-BioNTech | No |
| 3 | 2022-03-31 | Pfizer-BioNTech | No |
Free text
Release 11 — day 35, dose 3, dependent
Symptoms: Nausea, headache, chills, vomiting, heat flash, lethargy, short of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hot flush | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release